1
Clinical Trials associated with SNA02-48 / Not yet recruitingPhase 1/2 A Randomized, Double-Blind, Controlled, Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SNA02-48 Injection in Chinese Adult Participants
To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of the full human anti-tetanus toxin monoclonal antibody SNA02-48 injection and compare the Tetanus-antibody levels and safety of SNA02-48 with human tetanus immunoglobulin (HTIG) in Chinese adult participants.
100 Clinical Results associated with SNA02-48
100 Translational Medicine associated with SNA02-48
100 Patents (Medical) associated with SNA02-48
100 Deals associated with SNA02-48